UNRESECTABLE SALIVARY GLAND CARCINOMA
Clinical trials for UNRESECTABLE SALIVARY GLAND CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE SALIVARY GLAND CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE SALIVARY GLAND CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test 'One-Two Punch' against Tough-to-Treat cancers
Disease control Recruiting nowThis early-stage study is testing the safety and best dose of a new two-drug combination for people with advanced solid tumors that have a specific marker called HER2. The treatment pairs an existing targeted cancer drug with a new pill that aims to block cancer cells' ability to…
Matched conditions: UNRESECTABLE SALIVARY GLAND CARCINOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for Tough-to-Treat salivary gland cancers
Disease control Recruiting nowThis study is testing new targeted drug treatments for advanced salivary gland cancer that has returned, spread, or cannot be removed by surgery. It compares two newer drug combinations against a standard chemotherapy treatment to see which is better at controlling the cancer and…
Matched conditions: UNRESECTABLE SALIVARY GLAND CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC